UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 1, 2018
MEDICAL PROPERTIES TRUST, INC.
(Exact Name of Registrant as Specified in Charter)
Commission File Number 001-32559
Maryland | 20-0191742 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
1000 Urban Center Drive, Suite 501 Birmingham, AL |
35242 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code
(205) 969-3755
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. | Results of Operations and Financial Condition. |
On November 1, 2018, Medical Properties Trust, Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2018. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the information set forth in Exhibit 99.1 and Exhibit 99.2 attached hereto, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. In addition, this information shall not be deemed incorporated by reference in any filing of Medical Properties Trust, Inc. with the Securities and Exchange Commission, except as expressly set forth by specific reference in any such filing.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized.
MEDICAL PROPERTIES TRUST, INC. | ||
By: | /s/ R. Steven Hamner | |
Name: | R. Steven Hamner | |
Title: | Executive Vice President and Chief Financial Officer |
Date: November 1, 2018
3
Exhibit 99.1
Contact: Tim Berryman |
Director Investor Relations |
Medical Properties Trust, Inc. |
(205) 969-3755 tberryman@medicalpropertiestrust.com |
MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS
Positioned for $2.0 Billion in Accretive, Low-Levered Acquisitions
Updates 2018 and Introduces 2019 Estimates
Birmingham, AL November 1, 2018 Medical Properties Trust, Inc. (the Company or MPT) (NYSE: MPW) today announced financial and operating results for the third quarter ended September 30, 2018.
MPT successfully completed its planned capital recycling strategy during the third quarter and we have positioned ourselves uniquely among healthcare REITs for immediate and accretive growth. We have an outstanding balance sheet with sector-leading low leverage and approximately $2.0 billion in available liquidity at the same time our pipeline is the largest and best it has ever been, said Edward K. Aldag, Jr., MPTs Chairman, President and Chief Executive Officer. We think 2019 has the potential to be a monumental year for the Company with opportunity to deliver market-leading FFO and dividend growth from the very large, diverse and actionable acquisition pipeline that we have assembled.
THIRD QUARTER AND RECENT HIGHLIGHTS
| Net income of $2.00 and Normalized Funds from Operations (NFFO) of $0.35 in the third quarter, both on a per diluted share basis; |
| Completed the additions to the master lease of 5 Steward hospitals aggregating $811.4 million that were previously mortgaged to MPT (including 2 hospitals aggregating $273.7 million that were completed in the first half of 2018), substantially improving the credit characteristics of the Steward portfolio; |
| Completed the previously announced sale of MPTs equity investment in Ernest Health, Inc. in October resulting in total proceeds of approximately $176 million; |
| As previously announced, completed in August the joint venture with Primonial Real Estate Investment Management (Primonial) resulting in total proceeds of approximately 1.14 billion, and sold North Cypress Medical Center to Hospital Corporation of America for $148 million; |
| Repaid $820 million in outstanding revolver debt, resulting in approximately $1.3 billion in available liquidity from the revolving credit facility and pro forma net debt to EBITDA of approximately 4.5 times; |
| Completed acquisitions of three of the four previously announced German rehabilitation hospitals in August for 16.2 million; |
| Completed the previously announced acquisition of Lourdes Medical Center in Pasco, Washington in August for $17.5 million adding to the existing master lease with RCCH HealthCare Partners. |
Included in the financial tables accompanying this press release is information about the Companys assets and liabilities, net income and reconciliations of net income to NFFO, all on a basis comparable to 2017 results. In addition, a reconciliation of pro forma total gross assets to total assets is included in the financial tables accompanying this press release.
PORTFOLIO UPDATE
In the third quarter, and as previously disclosed, MPT completed its joint venture with Primonial and retained a 50% interest in the portfolio of 71 German post-acute hospitals valued at 1.63 billion.
Including its 50% portion of the joint venture with Primonial, MPT has pro forma total gross assets of approximately $9.6 billion, including $6.7 billion in general acute care hospitals, $1.6 billion in inpatient rehabilitation hospitals, and $0.3 billion in long-term acute care hospitals. This pro forma portfolio includes 276 properties representing more than 32,000 licensed beds in 29 states and in Germany, the United Kingdom, Italy and Spain. The properties are leased to or mortgaged by 29 hospital operating companies.
OPERATING RESULTS AND OUTLOOK
Net income for the third quarter of 2018 was $736.0 million (or $2.00 per diluted share), compared to $76.5 million (or $0.21 per diluted share) in the third quarter of 2017. The change from 2017s third quarter primarily results from gains on sales of assets in 2018.
NFFO for the third quarter of 2018 increased to $127.2 million compared with $120.6 million in the third quarter of 2017. Per share NFFO increased by 6.1% to $0.35 per diluted share in the third quarter of 2018, compared with $0.33 per diluted share in the third quarter of 2017. The Company achieved the strong growth in per share results even as the above-mentioned asset sales temporarily reduced revenues.
Based on managements present investment, capital and operating strategies, and the expected timing of each, management estimates that 2018 net income will approximate $2.76 per diluted share and that 2018 NFFO will approximate $1.36 per diluted share.
The Company today is also introducing its estimate of 2019 net income as a range of between $1.01 and $1.05 per diluted share and 2019 NFFO as a range of between $1.42 and $1.46 per
2
diluted share. This estimate assumes, among other estimates, that MPT will make acquisitions throughout 2019 aggregating approximately $2.0 billion, while maintaining a conservative debt profile.
These estimates do not include the effects, if any, of unexpected real estate operating costs, changes in accounting pronouncements, litigation costs, debt refinancing costs, acquisition costs, currency exchange rate movements, interest rate hedging activities, write-offs of straight-line rent or other non-recurring or unplanned transactions. These estimates may change if the Company acquires or sells assets, market interest rates change, debt is refinanced, new shares are issued, additional debt is incurred, other operating expenses vary, income from investments in tenant operations vary from expectations, or existing leases do not perform in accordance with their terms.
CONFERENCE CALL AND WEBCAST
The Company has scheduled a conference call and webcast for Thursday, November 1, 2018 at 11:00 a.m. Eastern Time to present the Companys financial and operating results for the quarter ended September 30, 2018. The dial-in numbers for the conference call are 855-365-5214 (U.S.) and 440-996-5721 (International); both numbers require passcode 5982137. The conference call will also be available via webcast in the Investor Relations section of the Companys website, www.medicalpropertiestrust.com.
A telephone and webcast replay of the call will be available beginning shortly after the calls completion through November 15, 2018. Dial-in numbers for the replay are 855-859-2056 and 404-537-3406 for U.S. and International callers, respectively. The replay passcode for both U.S. and International callers is 5982137.
The Companys supplemental information package for the current period will also be available on the Companys website under the Investor Relations section.
About Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPTs financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. For more information, please visit the Companys website at www.medicalpropertiestrust.com.
The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as expects, believes, anticipates, intends, will, should and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: the satisfaction of all conditions to,
3
and the timely closing (if at all) of pending transactions; net income per share for 2018 and 2019; NFFO per share for 2018 and 2019; resulting financial gains from pending transactions; the amount of acquisitions of healthcare real estate, if any; results from potential sales and joint venture arrangements, if any; capital markets conditions; estimated leverage metrics; the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in certain hospital operations and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangements, and additional investments; national and international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Companys business plan; financing risks; the Companys ability to maintain its status as a REIT for income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the Risk factors section of the Companys Annual Report on Form 10-K for the year ended December 31, 2017 and as updated by the Companys subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this press release.
# # #
4
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(Amounts in thousands, except for per share data) | September 30, 2018 | December 31, 2017 | ||||||
(Unaudited) | (A) | |||||||
Assets |
||||||||
Real estate assets |
||||||||
Land, buildings and improvements, intangible lease assets, and other |
$ | 4,926,462 | $ | 5,944,220 | ||||
Mortgage loans |
1,428,069 | 1,778,316 | ||||||
Net investment in direct financing leases |
690,897 | 698,727 | ||||||
|
|
|
|
|||||
Gross investment in real estate assets |
7,045,428 | 8,421,263 | ||||||
Accumulated depreciation and amortization |
(432,279 | ) | (455,712 | ) | ||||
|
|
|
|
|||||
Net investment in real estate assets |
6,613,149 | 7,965,551 | ||||||
Cash and cash equivalents |
710,965 | 171,472 | ||||||
Interest and rent receivables |
87,939 | 78,970 | ||||||
Straight-line rent receivables |
195,329 | 185,592 | ||||||
Other assets |
1,167,134 | 618,703 | ||||||
|
|
|
|
|||||
Total Assets |
$ | 8,774,516 | $ | 9,020,288 | ||||
|
|
|
|
|||||
Liabilities and Equity |
||||||||
Liabilities |
||||||||
Debt, net |
$ | 4,043,849 | $ | 4,898,667 | ||||
Accounts payable and accrued expenses |
202,033 | 211,188 | ||||||
Deferred revenue |
11,162 | 18,178 | ||||||
Lease deposits and other obligations to tenants |
30,964 | 57,050 | ||||||
|
|
|
|
|||||
Total Liabilities |
4,288,008 | 5,185,083 | ||||||
Equity |
||||||||
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding |
| | ||||||
Common stock, $0.001 par value. Authorized 500,000 shares; issued and outstanding - 364,858 shares at September 30, 2018 and 364,424 shares at December 31, 2017 |
365 | 364 | ||||||
Additional paid-in capital |
4,343,768 | 4,333,027 | ||||||
Retained earnings (deficit) |
179,703 | (485,932 | ) | |||||
Accumulated other comprehensive loss |
(50,569 | ) | (26,049 | ) | ||||
Treasury shares, at cost |
(777 | ) | (777 | ) | ||||
|
|
|
|
|||||
Total Medical Properties Trust, Inc. Stockholders' Equity |
4,472,490 | 3,820,633 | ||||||
Non-controlling interests |
14,018 | 14,572 | ||||||
|
|
|
|
|||||
Total Equity |
4,486,508 | 3,835,205 | ||||||
|
|
|
|
|||||
Total Liabilities and Equity |
$ | 8,774,516 | $ | 9,020,288 | ||||
|
|
|
|
(A) Financials have been derived from the prior year audited financial statements.
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Statements of Income
(Unaudited)
(Amounts in thousands, except for per share data) | For the Three Months Ended | For the Nine Months Ended | ||||||||||||||
September 30, 2018 | September 30, 2017 | September 30, 2018 | September 30, 2017 | |||||||||||||
Revenues |
||||||||||||||||
Rent billed |
$ | 118,238 | $ | 110,930 | $ | 369,076 | $ | 311,140 | ||||||||
Straight-line rent |
18,293 | 17,505 | 49,157 | 46,561 | ||||||||||||
Income from direct financing leases |
18,998 | 19,115 | 55,613 | 55,307 | ||||||||||||
Interest and fee income |
41,467 | 29,030 | 130,098 | 86,776 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenues |
196,996 | 176,580 | 603,944 | 499,784 | ||||||||||||
Expenses |
||||||||||||||||
Interest |
57,215 | 42,759 | 172,364 | 120,498 | ||||||||||||
Real estate depreciation and amortization |
29,949 | 31,915 | 100,217 | 88,994 | ||||||||||||
Property-related |
2,719 | 1,519 | 6,823 | 4,000 | ||||||||||||
General and administrative |
20,982 | 15,011 | 58,352 | 43,287 | ||||||||||||
Acquisition costs |
506 | 7,434 | 917 | 20,996 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total expenses |
111,371 | 98,638 | 338,673 | 277,775 | ||||||||||||
Other income (expense) |
||||||||||||||||
Gain on sale of real estate and other, net |
647,204 | 18 | 672,822 | 7,431 | ||||||||||||
Debt refinancing costs |
| (4,414 | ) | | (18,794 | ) | ||||||||||
Other |
5,711 | 3,865 | 6,245 | 8,999 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other income (expense) |
652,915 | (531 | ) | 679,067 | (2,364 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income before income tax |
738,540 | 77,411 | 944,338 | 219,645 | ||||||||||||
Income tax expense |
(2,064 | ) | (530 | ) | (4,802 | ) | (783 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
736,476 | 76,881 | 939,536 | 218,862 | ||||||||||||
Net income attributable to non-controlling interests |
(442 | ) | (417 | ) | (1,334 | ) | (1,013 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income attributable to MPT common stockholders |
$ | 736,034 | $ | 76,464 | $ | 938,202 | $ | 217,849 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Earnings per common share - basic: |
||||||||||||||||
Net income attributable to MPT common stockholders |
$ | 2.01 | $ | 0.21 | $ | 2.56 | $ | 0.63 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Earnings per common share - diluted: |
||||||||||||||||
Net income attributable to MPT common stockholders |
$ | 2.00 | $ | 0.21 | $ | 2.56 | $ | 0.63 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average shares outstanding - basic |
365,024 | 364,315 | 364,934 | 345,076 | ||||||||||||
Weighted average shares outstanding - diluted |
366,467 | 365,046 | 365,784 | 345,596 | ||||||||||||
Dividends declared per common share |
$ | 0.25 | $ | 0.24 | $ | 0.75 | $ | 0.72 |
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Reconciliation of Net Income to Funds From Operations
(Unaudited)
(Amounts in thousands, except for per share data) | For the Three Months Ended | For the Nine Months Ended | ||||||||||||||
September 30, 2018 | September 30, 2017 | September 30, 2018 | September 30, 2017 | |||||||||||||
FFO information: |
||||||||||||||||
Net income attributable to MPT common stockholders |
$ | 736,034 | $ | 76,464 | $ | 938,202 | $ | 217,849 | ||||||||
Participating securities' share in earnings |
(290 | ) | (82 | ) | (808 | ) | (307 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income, less participating securities' share in earnings |
$ | 735,744 | $ | 76,382 | $ | 937,394 | $ | 217,542 | ||||||||
Depreciation and amortization (A) |
32,641 | 32,618 | 104,314 | 90,744 | ||||||||||||
Gain on sale of real estate and other, net |
(647,204 | ) | (18 | ) | (672,822 | ) | (7,431 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Funds from operations |
$ | 121,181 | $ | 108,982 | $ | 368,886 | $ | 300,855 | ||||||||
Write-off of straight-line rent and other |
4,321 | | 17,615 | 1,117 | ||||||||||||
Debt refinancing costs |
| 4,414 | | 18,794 | ||||||||||||
Acquisition and other transaction costs, net of tax benefit (A) |
1,661 | 7,166 | 2,072 | 19,350 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Normalized funds from operations |
$ | 127,163 | $ | 120,562 | $ | 388,573 | $ | 340,116 | ||||||||
Share-based compensation |
4,970 | 2,771 | 11,695 | 7,148 | ||||||||||||
Debt costs amortization |
1,952 | 1,609 | 5,543 | 4,748 | ||||||||||||
Straight-line rent revenue and other (A) |
(26,743 | ) | (21,169 | ) | (74,544 | ) | (56,632 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted funds from operations |
$ | 107,342 | $ | 103,773 | $ | 331,267 | $ | 295,380 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Per diluted share data: |
||||||||||||||||
Net income, less participating securities' share in earnings |
$ | 2.00 | $ | 0.21 | $ | 2.56 | $ | 0.63 | ||||||||
Depreciation and amortization (A) |
0.09 | 0.09 | 0.29 | 0.26 | ||||||||||||
Gain on sale of real estate and other, net |
(1.76 | ) | | (1.84 | ) | (0.02 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Funds from operations |
$ | 0.33 | $ | 0.30 | $ | 1.01 | $ | 0.87 | ||||||||
Write-off of straight-line rent and other |
0.01 | | 0.04 | | ||||||||||||
Debt refinancing costs |
| 0.01 | | 0.05 | ||||||||||||
Acquisition and other transaction costs, net of tax benefit (A) |
0.01 | 0.02 | 0.01 | 0.06 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Normalized funds from operations |
$ | 0.35 | $ | 0.33 | $ | 1.06 | $ | 0.98 | ||||||||
Share-based compensation |
0.01 | 0.01 | 0.03 | 0.02 | ||||||||||||
Debt costs amortization |
0.01 | | 0.02 | 0.01 | ||||||||||||
Straight-line rent revenue and other (A) |
(0.08 | ) | (0.06 | ) | (0.20 | ) | (0.16 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted funds from operations |
$ | 0.29 | $ | 0.28 | $ | 0.91 | $ | 0.85 | ||||||||
|
|
|
|
|
|
|
|
(A) Includes our share of real estate depreciation, acquisition expenses and straight-line rent revenue from unconsolidated joint ventures. These amounts are included with the activity of all of our equity interests in the Other line on the consolidated statements of income.
Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.
In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.
We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) unbilled rent revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Fiscal Year 2018 and 2019 Guidance Reconciliation
(Unaudited)
Fiscal Year
2018 Guidance - Per Share(1) |
Fiscal Year 2019 Guidance - Per Share(1) | |||||||||||
Low | High | |||||||||||
Net income attributable to MPT common stockholders |
$ | 2.76 | $ | 1.01 | $ | 1.05 | ||||||
Participating securities' share in earnings |
| | | |||||||||
|
|
|
|
|
|
|||||||
Net income, less participating securities' share in earnings |
$ | 2.76 | $ | 1.01 | $ | 1.05 | ||||||
Depreciation and amortization |
0.39 | 0.40 | 0.40 | |||||||||
Gain on sale of real estate and other, net |
(1.84 | ) | | | ||||||||
|
|
|
|
|
|
|||||||
Funds from operations |
$ | 1.31 | $ | 1.41 | $ | 1.45 | ||||||
Other adjustments |
0.05 | 0.01 | 0.01 | |||||||||
|
|
|
|
|
|
|||||||
Normalized funds from operations |
$ | 1.36 | $ | 1.42 | $ | 1.46 | ||||||
|
|
|
|
|
|
(1) | The guidance is based on current expectations and actual results or future events may differ materially from those expressed in this table, which is a forward-looking statement within the meaning of the federal securities laws. Please refer to the forward-looking statement included in this press release and our filings with the Securities and Exchange Commission for a discussion of risk factors that affect our performance. |
Pro Forma Total Gross Assets
(Unaudited)
September 30, 2018 | ||||
Total Assets |
$ | 8,774,516 | ||
Add: |
||||
Binding real estate commitments on new investments(1) |
7,897 | |||
Unfunded amounts on development deals and commenced capital improvement projects(2) |
208,497 | |||
Accumulated depreciation and amortization |
432,279 | |||
Incremental gross assets of our joint ventures(3) |
380,031 | |||
Less: |
||||
Cash and cash equivalents |
(216,394 | ) | ||
|
|
|||
Pro Forma Total Gross Assets(4) |
$ | 9,586,826 | ||
|
|
(1) | Reflects a commitment to acquire a facility in Germany post September 30, 2018. |
(2) | Includes $119.9 million unfunded amounts on ongoing development projects and $88.6 million unfunded amounts on capital improvement projects and development projects that have commenced rent. |
(3) | Adjustment needed to reflect our share of our joint ventures gross assets. |
(4) | Pro forma total gross assets is total assets before accumulated depreciation/amortization, assumes all real estate binding commitments on new investments and unfunded amounts on development deals and commenced capital improvement projects are fully funded, and assumes cash on hand is fully used in these transactions. We believe pro forma total gross assets is useful to investors as it provides a more current view of our portfolio and allows for a better understanding of our concentration levels as our binding commitments close and our other commitments are fully funded. |
Exhibit 99.2
Medical Properties Trust THIRD QUARTER 2018 Supplemental Information
MEDICALPROPERTIESTRUST.COM TABLE OF CONTENTS COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income
to Funds from Operations 5 Debt Summary 6 Debt Maturity Schedule 7 Pro Forma Net Debt /Annualized Adjusted EBITDA 8 PORTFOLIO INFORMATION Lease and Mortgage Loan Maturity Schedule 9 Total Pro Forma Gross Assets and Actual Revenue by Asset Type,
Operator, State and Country 10 EBITDARM to Rent Coverage 13 Summary of Acquisitions and Development Projects 14 FINANCIAL STATEMENTS Consolidated Statements of Income 15 FORWARD-LOOKING STATEMENT Forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: Normalized FFO per
share; expected payout ratio, the amount of acquisitions of healthcare real estate, if any; estimated debt metrics, portfolio diversification, capital markets conditions, the repayment of debt arrangements; statements concerning the additional
income to the Company as a result of ownership interests in certain hospital operations and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangement, and additional investments; national and
international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Companys business plan; financing risks; the Companys ability to maintain its
status as a REIT for federal income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further
discussion of the factors that could affect outcomes, please refer to the Risk Factors section of the Companys Annual Report on Form 10-K for the year ended December 31, 2017, and as updated by the Companys subsequently filed
Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this report. On the Cover: Clinica Eporediese which is an MPT-owned
acute care hospital in Ivrea, Italy.
Q3 2018 | SUPPLEMENTAL INFORMATION 2
MEDICALPROPERTIESTRUST.COM COMPANY OVERVIEW Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPTs financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. OFFICERS Edward K. Aldag, Jr. R. Steven Hamner Emmett E. McLean J. Kevin Hanna Rosa H. Hooper Charles R. Lambert BOARD OF DIRECTORS Edward K. Aldag, Jr. G. Steven Dawson R. Steven Hamner Elizabeth N. Pitman D. Paul Sparks, Jr. Michael G. Stewart C. Reynolds Thompson, III CORPORATE HEADQUARTERS Medical Properties Trust, Inc. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 (205) 969-3755 (205) 969-3756 (fax) www.medicalpropertiestrust.com Chairman, President and Chief Executive Officer Executive Vice President and Chief Financial Officer Executive Vice President, Chief Operating Officer and Secretary Vice President, Controller and Chief Accounting Officer Vice President, Managing Director of Asset Management and Underwriting Treasurer and Managing Director of Capital Markets MPT Officers: R. Steven Hamner, Emmett E. McLean, Edward K. Aldag, Jr., Rosa H. Hooper, J. Kevin Hanna and Charles R. Lambert Q3 2018 | SUPPLEMENTAL INFORMATION 3
MEDICALPROPERTIESTRUST.COM COMPANY OVERVIEW (continued) INVESTOR RELATIONS CAPITAL MARKETS Tim Berryman Charles Lambert Director - Investor Relations Treasurer and Managing Director - Capital Markets (205) 397-8589 tberryman@medicalpropertiestrust.com (205) 397-8897 clambert@medicalpropertiestrust.com TRANSFER AGENT STOCK EXCHANGE SENIOR UNSECURED American Stock Transfer LISTING AND DEBT RATINGS and Trust Company TRADING SYMBOL Moodys Ba1 6201 15th Avenue New York Stock Exchange Standard & Poors BBB-Brooklyn, NY 11219 (NYSE): MPW CONTINUUM OF CARE R E Medical Properties Trust focuses on the most H I G H critical components of healthcare delivery. ACUTE CARE HOSPITALS ACUTE CARE HOSPITALS & FREE STANDING EMERGENCY ROOMS INPATIENT REHABILITATION FACILITIES LONG-TERM ACUTE CARE HOSPITALS NURSING HOMES INPATIENT ASSISTED LIVING REHABILITATION FACILITIES HOME HEALTH CARE MPT facility types shown in green. HOME LONG-TERM HEALTH ACUTE CARE CARE I HOSPITALS N T E ASSISTED N S NURSING LIVING I T HOMES YO FC AR E LOWER Q3 2018 | SUPPLEMENTAL INFORMATION 4
MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
RECONCILIATION OF NET INCOME TO FUNDS FROM OPERATIONS
(Amounts in thousands, except per share data)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
September 30, 2018 | September 30, 2017 | September 30, 2018 | September 30, 2017 | |||||||||||||
FFO INFORMATION: |
||||||||||||||||
Net income attributable to MPT common stockholders |
$ | 736,034 | $ | 76,464 | $ | 938,202 | $ | 217,849 | ||||||||
Participating securities share in earnings |
(290 | ) | (82 | ) | (808 | ) | (307 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income, less participating securities share in earnings |
$ | 735,744 | $ | 76,382 | $ | 937,394 | $ | 217,542 | ||||||||
Depreciation and amortization (A) |
32,641 | 32,618 | 104,314 | 90,744 | ||||||||||||
Gain on sale of real estate and other, net |
(647,204 | ) | (18 | ) | (672,822 | ) | (7,431 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Funds from operations |
$ | 121,181 | $ | 108,982 | $ | 368,886 | $ | 300,855 | ||||||||
Write-off of straight-line rent and other |
4,321 | | 17,615 | 1,117 | ||||||||||||
Debt refinancing costs |
| 4,414 | | 18,794 | ||||||||||||
Acquisition and other transaction costs, net of tax benefit (A) |
1,661 | 7,166 | 2,072 | 19,350 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Normalized funds from operations |
$ | 127,163 | $ | 120,562 | $ | 388,573 | $ | 340,116 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Share-based compensation |
4,970 | 2,771 | 11,695 | 7,148 | ||||||||||||
Debt costs amortization |
1,952 | 1,609 | 5,543 | 4,748 | ||||||||||||
Straight-line rent revenue and other (A) |
(26,743 | ) | (21,169 | ) | (74,544 | ) | (56,632 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted funds from operations |
$ | 107,342 | $ | 103,773 | $ | 331,267 | $ | 295,380 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
PER DILUTED SHARE DATA: |
||||||||||||||||
Net income, less participating securities share in earnings |
$ | 2.00 | $ | 0.21 | $ | 2.56 | $ | 0.63 | ||||||||
Depreciation and amortization (A) |
0.09 | 0.09 | 0.29 | 0.26 | ||||||||||||
Gain on sale of real estate and other, net |
(1.76 | ) | | (1.84 | ) | (0.02 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Funds from operations |
$ | 0.33 | $ | 0.30 | $ | 1.01 | $ | 0.87 | ||||||||
Write-off of straight-line rent and other |
0.01 | | 0.04 | | ||||||||||||
Debt refinancing costs |
| 0.01 | | 0.05 | ||||||||||||
Acquisition and other transaction costs, net of tax benefit (A) |
0.01 | 0.02 | 0.01 | 0.06 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Normalized funds from operations |
$ | 0.35 | $ | 0.33 | $ | 1.06 | $ | 0.98 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Share-based compensation |
0.01 | 0.01 | 0.03 | 0.02 | ||||||||||||
Debt costs amortization |
0.01 | | 0.02 | 0.01 | ||||||||||||
Straight-line rent revenue and other (A) |
(0.08 | ) | (0.06 | ) | (0.20 | ) | (0.16 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted funds from operations |
$ | 0.29 | $ | 0.28 | $ | 0.91 | $ | 0.85 | ||||||||
|
|
|
|
|
|
|
|
(A) | Includes our share of real estate depreciation, acquisition expenses and straight-line rent revenue from unconsolidated joint ventures. These amounts are included with the activity of all of our equity interests in the Other line on the consolidated statements of income. |
Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.
In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.
We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) unbilled rent revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.
Q3 2018 | SUPPLEMENTAL INFORMATION 5
MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
DEBT SUMMARY
(as of September 30, 2018)
($ amounts in thousands)
Debt Instrument |
Rate Type | Rate | Balance | |||||||||
2021 Credit Facility Revolver (£17M) (A) |
Variable | 1.980 | % | $ | 22,153 | |||||||
2022 Term Loan |
Variable | 3.650 | % | 200,000 | ||||||||
4.000% Notes Due 2022 (500M) (B) |
Fixed | 4.000 | % | 580,200 | ||||||||
6.375% Notes Due 2024 |
Fixed | 6.375 | % | 500,000 | ||||||||
5.500% Notes Due 2024 |
Fixed | 5.500 | % | 300,000 | ||||||||
3.325% Notes Due 2025 (500M) (B) |
Fixed | 3.325 | % | 580,200 | ||||||||
5.250% Notes Due 2026 |
Fixed | 5.250 | % | 500,000 | ||||||||
5.000% Notes Due 2027 |
Fixed | 5.000 | % | 1,400,000 | ||||||||
|
|
|||||||||||
$ | 4,082,553 | |||||||||||
Debt issuance costs |
(38,704 | ) | ||||||||||
|
|
|
|
|||||||||
Weighted average rate | 4.773 | % | $ | 4,043,849 | ||||||||
|
|
|
|
(A) Represents credit facility borrowings in pound sterling and converted to U.S. dollars at September 30, 2018.
(B) Represents bonds issued in euros and converted to U.S. dollars at September 30, 2018.
Q3 2018 | SUPPLEMENTAL INFORMATION 6
MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
DEBT MATURITY SCHEDULE
($ amounts in thousands)
Debt Instrument |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||||||||||||||||||||||||||||||
2021 Credit Facility Revolver (£17M) |
$ | | $ | | $ | | $ | 22,153 | $ | | $ | | $ | | $ | | $ | | $ | | ||||||||||||||||||||
2022 Term Loan |
| | | | 200,000 | | | | | | ||||||||||||||||||||||||||||||
4.000% Notes Due 2022 (500M) |
| | | | 580,200 | | | | | | ||||||||||||||||||||||||||||||
6.375% Notes Due 2024 |
| | | | | | 500,000 | | | | ||||||||||||||||||||||||||||||
5.500% Notes Due 2024 |
| | | | | | 300,000 | | | | ||||||||||||||||||||||||||||||
3.325% Notes Due 2025 (500M) |
| | | | | | | 580,200 | | | ||||||||||||||||||||||||||||||
5.250% Notes Due 2026 |
| | | | | | | | 500,000 | | ||||||||||||||||||||||||||||||
5.000% Notes Due 2027 |
| | | | | | | | | 1,400,000 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | | $ | | $ | | $ | 22,153 | $ | 780,200 | $ | | $ | 800,000 | $ | 580,200 | $ | 500,000 | $ | 1,400,000 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q3 2018 | SUPPLEMENTAL INFORMATION 7
MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
PRO FORMA NET DEBT / ANNUALIZED ADJUSTED EBITDA
(Amounts in thousands)
For the Three Months Ended | ||||
September 30, 2018 | ||||
Net income attributable to MPT common stockholders |
$ | 736,034 | ||
Pro forma adjustments for mid-quarter acquisitions/dispositions and acquisitions that occurred after the period (A) |
(18,782 | ) | ||
|
|
|||
Pro forma net income |
$ | 717,252 | ||
Add back: |
||||
Interest |
57,215 | |||
Depreciation and amortization (B) |
34,759 | |||
Share-based compensation |
4,970 | |||
Gain on sale of real estate and other, net |
(647,204 | ) | ||
Write-off of straight-line rent and other |
4,321 | |||
Acquisition and other transaction costs |
1,661 | |||
Income tax expense (B) |
2,379 | |||
|
|
|||
3Q 2018 Pro forma adjusted EBITDA |
$ | 175,353 | ||
|
|
|||
Annualization |
$ | 701,412 | ||
|
|
|||
Total debt |
$ | 4,043,849 | ||
Pro forma changes to cash and debt balance after September 30, 2018 (A) |
(911,285 | ) | ||
|
|
|||
Pro forma net debt |
$ | 3,132,564 | ||
|
|
|||
Pro forma net debt / annualized adjusted EBITDA |
4.5x |
(A) | The schedule reflects transactions closed in October 2018 and our commitment to acquire one facility in Germany. |
(B) | Includes our share of real estate depreciation and income tax expense from unconsolidated joint ventures. |
Investors and analysts following the real estate industry utilize net debt (debt less cash) to EBITDA (net income before interest expense, income taxes, depreciation and amortization) as a measurement of leverage that shows how many years it would take for us to pay back our debt, assuming net debt and EBITDA are held constant. The table above considers the pro forma effects on net debt and EBITDA from investments and capital transactions that were either completed during the period or disclosed as firm commitments, assuming such transactions were consummated/fully funded as of the beginning of the period. In addition, we show EBITDA adjusted to exclude stock compensation expense, gains or losses on real estate and other dispositions, debt refinancing charges, impairment charges, and other non-cash charges to derive Pro forma Annualized Adjusted EBITDA, which is a non-GAAP measure. We believe Pro forma Net Debt and Pro forma Annualized Adjusted EBITDA are useful to investors and analysts as they allow for a more current view of our credit quality and allow for the comparison of our credit strength between periods and to other real estate companies without the effect of items that by their nature are not comparable from period to period.
Q3 2018 | SUPPLEMENTAL INFORMATION 8
MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
LEASE AND MORTGAGE LOAN MATURITY SCHEDULE
(as of September 30, 2018)
($ amounts in thousands)
Years of Maturities (A) |
Total Properties (B) | Base Rent/Interest (C) | Percent of Total Base Rent/Interest |
|||||||||
2018 |
| $ | | | ||||||||
2019 |
4 | 8,641 | 1.3 | % | ||||||||
2020 |
1 | 2,073 | 0.3 | % | ||||||||
2021 |
1 | 2,250 | 0.3 | % | ||||||||
2022 |
15 | 75,445 | 11.4 | % | ||||||||
2023 |
4 | 13,149 | 2.0 | % | ||||||||
2024 |
2 | 5,401 | 0.8 | % | ||||||||
2025 |
6 | 19,933 | 3.0 | % | ||||||||
2026 |
5 | 25,694 | 3.9 | % | ||||||||
2027 |
1 | 3,051 | 0.5 | % | ||||||||
2028 |
5 | 7,158 | 1.1 | % | ||||||||
Thereafter |
220 | 497,683 | 75.4 | % | ||||||||
|
|
|
|
|
|
|||||||
264 | $ | 660,478 | 100.0 | % | ||||||||
|
|
|
|
|
|
(A) | Lease/Loan expiration is based on the fixed term of the lease/loan and does not factor in potential renewal options provided for in our agreements. |
(B) | Includes all properties including those that are part of joint ventures, except nine vacant properties representing 0.7% of total pro forma gross assets and three facilities that are under development. The schedule also includes a previously disclosed commitment to acquire one facility in Germany. |
(C) | Represents base rent/interest income on an annualized basis but does not include tenant recoveries, additional rents and other lease-related adjustments to revenue (i.e., straight-line rents and deferred revenues). |
Q3 2018 | SUPPLEMENTAL INFORMATION 9
MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
TOTAL PRO FORMA GROSS ASSETS AND ACTUAL REVENUE BY ASSET TYPE
(September 30, 2018)
($ amounts in thousands)
Asset Types |
Total Pro Forma Gross Assets (B) |
Percentage of Pro Forma Gross Assets |
YTD Actual Revenue (C) |
Percentage of Total Actual Revenue |
||||||||||||
General Acute Care Hospitals (A) |
$ | 6,677,798 | 69.6 | % | $ | 449,445 | 72.8 | % | ||||||||
Inpatient Rehabilitation Hospitals |
1,573,936 | 16.4 | % | 145,442 | 23.5 | % | ||||||||||
Long-Term Acute Care Hospitals |
282,906 | 3.0 | % | 22,805 | 3.7 | % | ||||||||||
Other assets |
1,052,186 | 11.0 | % | | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 9,586,826 | 100.0 | % | $ | 617,692 | 100.0 | % | ||||||||
|
|
|
|
|
|
|
|
(A) | Includes three medical office buildings. |
(B) | Represents investment concentration as a percentage of gross real estate assets, other loans, equity investments, and pro rata portion of gross assets in joint venture arrangements, assuming all binding real estate commitments on new investments and unfunded amounts on development deals and commenced capital improvement projects are fully funded. See press release dated November 1, 2018 for reconciliation of total assets to pro forma total gross assets at September 30, 2018. |
(C) | Includes revenue from properties owned through joint venture arrangements. |
Q3 2018 | SUPPLEMENTAL INFORMATION 10
MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
TOTAL PRO FORMA GROSS ASSETS AND ACTUAL REVENUE BY OPERATOR
(September 30, 2018)
($ amounts in thousands)
Operators |
Total Pro Forma Gross Assets (A) |
Percentage of Pro Forma Gross Assets (B) |
YTD Actual Revenue (C) |
Percentage of Total Actual Revenue |
||||||||||||
Steward |
||||||||||||||||
Massachusetts market |
$ | 1,378,535 | 14.4 | % | $ | 85,055 | 13.8 | % | ||||||||
Utah market |
991,701 | 10.3 | % | 58,849 | 9.5 | % | ||||||||||
Texas/Arkansas/Louisiana market |
592,708 | 6.2 | % | 38,476 | 6.3 | % | ||||||||||
Arizona market |
279,242 | 2.9 | % | 20,505 | 3.3 | % | ||||||||||
Florida market |
196,675 | 2.1 | % | 9,977 | 1.6 | % | ||||||||||
Ohio/Pennsylvania market |
182,799 | 1.9 | % | 13,127 | 2.1 | % | ||||||||||
Prime Healthcare |
1,123,350 | 11.7 | % | 95,439 | 15.5 | % | ||||||||||
MEDIAN |
1,091,987 | 11.4 | % | 99,924 | 16.2 | % | ||||||||||
RCCH |
506,267 | 5.3 | % | 31,484 | 5.1 | % | ||||||||||
Ernest Health |
499,335 | 5.2 | % | 52,752 | 8.5 | % | ||||||||||
24 operators |
1,692,041 | 17.6 | % | 112,104 | 18.1 | % | ||||||||||
Other assets |
1,052,186 | 11.0 | % | | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 9,586,826 | 100.0 | % | $ | 617,692 | 100.0 | % | ||||||||
|
|
|
|
|
|
|
|
(A) | Represents investment concentration as a percentage of gross real estate assets, other loans, equity investments, and pro rata portion of gross assets in joint venture arrangements, assuming all binding real estate commitments on new investments and unfunded amounts on development deals and commenced capital improvement projects are fully funded. See press release dated November 1, 2018 for reconciliation of total assets to pro forma total gross assets at September 30, 2018. |
(B) | No single facility accounts for more than 3.7% of total pro forma gross assets. |
(C) | Includes revenue from properties owned through joint venture arrangements. |
Q3 2018 | SUPPLEMENTAL INFORMATION 11
MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
TOTAL PRO FORMA GROSS ASSETS AND ACTUAL REVENUE BY U.S. STATE AND COUNTRY
(September 30, 2018)
($ amounts in thousands)
U.S. States and Other Countries |
Total Pro Forma Gross Assets (A) |
Percentage of Pro Forma Gross Assets |
YTD Actual Revenue (B) |
Percentage of Total Actual Revenue |
||||||||||||
Massachusetts |
$ | 1,378,535 | 14.4 | % | $ | 85,054 | 13.8 | % | ||||||||
Texas |
1,109,034 | 11.6 | % | 87,588 | 14.2 | % | ||||||||||
Utah |
1,026,296 | 10.7 | % | 62,598 | 10.1 | % | ||||||||||
California |
522,756 | 5.5 | % | 45,326 | 7.3 | % | ||||||||||
Arizona |
479,582 | 5.0 | % | 35,204 | 5.7 | % | ||||||||||
24 Other States |
2,614,526 | 27.1 | % | 184,091 | 29.8 | % | ||||||||||
Other assets |
497,916 | 5.2 | % | | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
United States |
$ | 7,628,645 | 79.5 | % | $ | 499,861 | 80.9 | % | ||||||||
Germany |
$ | 1,182,318 | 12.3 | % | $ | 106,198 | 17.2 | % | ||||||||
United Kingdom |
103,013 | 1.1 | % | 2,895 | 0.5 | % | ||||||||||
Italy |
92,742 | 1.0 | % | 6,059 | 1.0 | % | ||||||||||
Spain |
25,838 | 0.3 | % | 2,679 | 0.4 | % | ||||||||||
Other assets |
554,270 | 5.8 | % | | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
International |
$ | 1,958,181 | 20.5 | % | $ | 117,831 | 19.1 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 9,586,826 | 100.0 | % | $ | 617,692 | 100.0 | % | ||||||||
|
|
|
|
|
|
|
|
(A) | Represents investment concentration as a percentage of gross real estate assets, other loans, equity investments, and pro rata portion of gross assets in joint venture arrangements, assuming all binding real estate commitments on new investments and unfunded amounts on development deals and commenced capital improvement projects are fully funded. See press release dated November 1, 2018 for reconciliation of total assets to pro forma total gross assets at September 30, 2018. |
(B) | Includes revenue from properties owned through joint venture arrangements. |
Q3 2018 | SUPPLEMENTAL INFORMATION 12
MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
Same Store EBITDARM(1) Rent Coverage
YOY and Sequential Quarter Comparisons by Property Type
Stratification of Portfolio EBITDARM Rent Coverage
EBITDARM Rent Coverage TTM |
Investment (in thousands) |
No. of Facilities | Percentage of Investment |
|||||||||
Greater than or equal to 4.50x |
$ | 132,979 | 4 | 3.4 | % | |||||||
3.00x - 4.49x |
$ | 118,934 | 2 | 3.0 | % | |||||||
1.50x - 2.99x |
$ | 78,706 | 5 | 2.0 | % | |||||||
Less than 1.50x |
$ | 3,199 | 1 | 0.1 | % | |||||||
Total Master Leased, Cross-Defaulted and/or with Parent Guaranty: 2.2x |
$ | 3,578,762 | 119 | 91.5 | % | |||||||
General Acute Master Leased, Cross-Defaulted and/or with Parent Guaranty: 3.8x |
$ | 2,061,135 | 41 | 52.7 | % | |||||||
Inpatient Rehabilitation Facilities Master Leased, Cross-Defaulted and/or with Parent Guaranty: 2.0x |
$ | 1,234,731 | 65 | 31.6 | % | |||||||
Long-Term Acute Care Hospitals Master Leased, Cross-Defaulted and/or with Parent Guaranty: 1.5x |
$ | 282,896 | 13 | 7.2 | % |
Notes:
Same Store represents properties with at least 24 months of financial reporting data. Properties that do not provide financial reporting and disposed assets are not included.
All data presented is on a trailing twelve month basis.
(1) | EBITDARM adjusted for non-recurring items. |
Q3 2018 | SUPPLEMENTAL INFORMATION 13
MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
SUMMARY OF COMPLETED ACQUISITIONS / DEVELOPMENT PROJECTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018
($ amounts in thousands)
Operator |
Location | Costs Incurred as of 9/30/2018 |
Rent Commencement Date |
Acquisition/ | ||||||||||
Ernest Health |
Flagstaff, Arizona | $ | 25,513 | 3/1/2018 | Development | |||||||||
MEDIAN |
Germany | 18,797 | 8/28/2018 | Acquisition | ||||||||||
RCCH |
Pasco, Washington | 17,500 | 8/31/2018 | Acquisition | ||||||||||
|
|
|||||||||||||
$ | 61,810 | |||||||||||||
|
|
|||||||||||||
SUMMARY OF CURRENT INVESTMENT COMMITMENTS AS OF SEPTEMBER 30, 2018 ($ amounts in thousands) | ||||||||||||||
Operator |
Location | Commitment | Acquisition/ Development |
|||||||||||
MEDIAN |
Germany | $ | 7,897 | Acquisition | ||||||||||
|
|
|||||||||||||
$ | 7,897 | |||||||||||||
|
|
|||||||||||||
SUMMARY OF CURRENT DEVELOPMENT PROJECTS AS OF SEPTEMBER 30, 2018 ($ amounts in thousands) | ||||||||||||||
Operator |
Location | Commitment | Cost Incurred as of 9/30/2018 |
Estimated Rent | ||||||||||
Circle Health |
United Kingdom | $ | 44,228 | (A) | $ | 24,113 | Q1 2019 | |||||||
Circle Health Rehabilitation |
United Kingdom | 21,973 | (B) | 5,304 | Q3 2019 | |||||||||
Surgery Partners |
Idaho Falls, Idaho | 113,468 | 30,379 | Q1 2020 | ||||||||||
|
|
|
|
|||||||||||
$ | 179,669 | $ | 59,796 | |||||||||||
|
|
|
|
(A) Represents £33,940 commitment converted to USD at September 30, 2018.
(B) Represents £16,862 commitment converted to USD at September 30, 2018.
Q3 2018 | SUPPLEMENTAL INFORMATION 14
MEDICALPROPERTIESTRUST.COM
FINANCIAL STATEMENTS
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Statements of Income
(Unaudited)
(Amounts in thousands, except per share data)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
September 30, 2018 | September 30, 2017 | September 30, 2018 | September 30, 2017 | |||||||||||||
Revenues |
||||||||||||||||
Rent billed |
$ | 118,238 | $ | 110,930 | $ | 369,076 | $ | 311,140 | ||||||||
Straight-line rent |
18,293 | 17,505 | 49,157 | 46,561 | ||||||||||||
Income from direct financing leases |
18,998 | 19,115 | 55,613 | 55,307 | ||||||||||||
Interest and fee income |
41,467 | 29,030 | 130,098 | 86,776 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenues |
196,996 | 176,580 | 603,944 | 499,784 | ||||||||||||
Expenses |
||||||||||||||||
Interest |
57,215 | 42,759 | 172,364 | 120,498 | ||||||||||||
Real estate depreciation and amortization |
29,949 | 31,915 | 100,217 | 88,994 | ||||||||||||
Property-related |
2,719 | 1,519 | 6,823 | 4,000 | ||||||||||||
General and administrative |
20,982 | 15,011 | 58,352 | 43,287 | ||||||||||||
Acquisition costs |
506 | 7,434 | 917 | 20,996 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total expenses |
111,371 | 98,638 | 338,673 | 277,775 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other income (expense) |
||||||||||||||||
Gain on sale of real estate and other, net |
647,204 | 18 | 672,822 | 7,431 | ||||||||||||
Debt refinancing costs |
| (4,414 | ) | | (18,794 | ) | ||||||||||
Other |
5,711 | 3,865 | 6,245 | 8,999 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other income (expense) |
652,915 | (531 | ) | 679,067 | (2,364 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income before income tax |
738,540 | 77,411 | 944,338 | 219,645 | ||||||||||||
Income tax expense |
(2,064 | ) | (530 | ) | (4,802 | ) | (783 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
736,476 | 76,881 | 939,536 | 218,862 | ||||||||||||
Net income attributable to non-controlling interests |
(442 | ) | (417 | ) | (1,334 | ) | (1,013 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income attributable to MPT common stockholders |
$ | 736,034 | $ | 76,464 | $ | 938,202 | $ | 217,849 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Earnings per common share basic: |
||||||||||||||||
Net income attributable to MPT common stockholders |
$ | 2.01 | $ | 0.21 | $ | 2.56 | $ | 0.63 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Earnings per common share diluted: |
||||||||||||||||
Net income attributable to MPT common stockholders |
$ | 2.00 | $ | 0.21 | $ | 2.56 | $ | 0.63 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average shares outstanding basic |
365,024 | 364,315 | 364,934 | 345,076 | ||||||||||||
Weighted average shares outstanding diluted |
366,467 | 365,046 | 365,784 | 345,596 | ||||||||||||
Dividends declared per common share |
$ | 0.25 | $ | 0.24 | $ | 0.75 | $ | 0.72 |
Q3 2018 | SUPPLEMENTAL INFORMATION 15
MEDICALPROPERTIESTRUST.COM
FINANCIAL STATEMENTS
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(Amounts in thousands, except per share data)
September 30, 2018 |
December 31, 2017 |
|||||||
(Unaudited) | (A) | |||||||
ASSETS |
||||||||
Real estate assets |
||||||||
Land, buildings and improvements, intangible lease assets, and other |
$ | 4,926,462 | $ | 5,944,220 | ||||
Mortgage loans |
1,428,069 | 1,778,316 | ||||||
Net investment in direct financing leases |
690,897 | 698,727 | ||||||
|
|
|
|
|||||
Gross investment in real estate assets |
7,045,428 | 8,421,263 | ||||||
Accumulated depreciation and amortization |
(432,279 | ) | (455,712 | ) | ||||
|
|
|
|
|||||
Net investment in real estate assets |
6,613,149 | 7,965,551 | ||||||
Cash and cash equivalents |
710,965 | 171,472 | ||||||
Interest and rent receivables |
87,939 | 78,970 | ||||||
Straight-line rent receivables |
195,329 | 185,592 | ||||||
Other assets |
1,167,134 | 618,703 | ||||||
|
|
|
|
|||||
Total Assets |
$ | 8,774,516 | $ | 9,020,288 | ||||
|
|
|
|
|||||
LIABILITIES AND EQUITY |
||||||||
Liabilities |
||||||||
Debt, net |
$ | 4,043,849 | $ | 4,898,667 | ||||
Accounts payable and accrued expenses |
202,033 | 211,188 | ||||||
Deferred revenue |
11,162 | 18,178 | ||||||
Lease deposits and other obligations to tenants |
30,964 | 57,050 | ||||||
|
|
|
|
|||||
Total Liabilities |
4,288,008 | 5,185,083 | ||||||
Equity |
||||||||
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding |
| | ||||||
Common stock, $0.001 par value. Authorized 500,000 shares; issued and outstanding - 364,858 shares at September 30, 2018 and 364,424 shares at December 31, 2017 |
365 | 364 | ||||||
Additional paid-in capital |
4,343,768 | 4,333,027 | ||||||
Retained earnings (deficit) |
179,703 | (485,932 | ) | |||||
Accumulated other comprehensive loss |
(50,569 | ) | (26,049 | ) | ||||
Treasury shares, at cost |
(777 | ) | (777 | ) | ||||
|
|
|
|
|||||
Total Medical Properties Trust, Inc. Stockholders Equity |
4,472,490 | 3,820,633 | ||||||
Non-controlling interests |
14,018 | 14,572 | ||||||
|
|
|
|
|||||
Total Equity |
4,486,508 | 3,835,205 | ||||||
|
|
|
|
|||||
Total Liabilities and Equity |
$ | 8,774,516 | $ | 9,020,288 | ||||
|
|
|
|
(A) | Financials have been derived from the prior year audited financial statements. |
Q3 2018 | SUPPLEMENTAL INFORMATION 16
1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 (205) 969-3755 NYSE: MPW www.medicalpropertiestrust.com Contact: Tim Berryman, DirectorInvestor Relations (205) 397-8589 or tberryman@medicalpropertiestrust.com or Charles Lambert, Treasurer and Managing DirectorCapital Markets (205) 397-8897 or clambert@medicalpropertiestrust.com At the Very heArt of heAlthcAre® .